News

By renewing our driver’s license at the DMV, most of us are aware of the process of registering to become an organ donor should the worst come to pass. But there is another group of organ donors — living donors — who are helping relatives, friends and even strangers by donating a kidney or part of their liver. Living donors who choose to give a kidney — the most commonly donated organ — can live a full life with the remaining kidney.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.